IRCWF yields 14492.75% · PFE yields 6.20%● Live data
📍 IRCWF pulled ahead of the other in Year 1
Combined, IRCWF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IRCWF + PFE for your $10,000?
IRC Limited, an investment holding company, develops, produces, and sells industrial commodities products in the Russia, People's Republic of China, and internationally. The company operates through four segments: Mines in Production, Mines in Development, Engineering, and Other. The Mines in Production segment comprises iron ore projects in production phase, which include the Kimkan and Sutara project located in the Obluchenskoye district of the Jewish Autonomous Region in the Russian Far East. The Mines in Development segment consists of iron ore projects in the exploration and development phase comprising the Garinskoye project that focuses on iron ore deposits in the Amur region; Kostenginskoye project; and the Bolshoi Seym project that explores for ilmenomagnetite, magnetite, and ilmenite located in the located in the Tynda district of Amur region in the Russian Far East region. The Engineering segment provides technical mining research and consultancy services. The Other segment engages in the production of vanadium pentoxides and related products, and other projects. It is also involved in the provision of general trading, financing, engineering, and procurement services; and development of titanium sponge. The company was incorporated in 2010 and is headquartered in Central, Hong Kong.
Full IRCWF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.